Extracellular

Extracellular is a pioneering company based in the UK, dedicated to advancing the field of biotechnology through innovative research and development. Our core mission is to harness the power of extracellular vesicles (EVs) to revolutionise therapeutic delivery systems and diagnostics.

Founded by a team of experienced scientists and industry experts, Extracellular focuses on the isolation, characterisation, and application of EVs in various medical fields. We believe that these tiny vesicles hold the key to unlocking new treatment modalities for diseases such as cancer, neurodegenerative disorders, and cardiovascular conditions.

Our Vision

At Extracellular, we envision a future where EV-based therapies are at the forefront of personalised medicine. Our commitment to scientific excellence drives us to collaborate with leading academic institutions and healthcare organisations to accelerate the translation of our research into clinical applications.

Core Activities

• Research & Development: We invest heavily in R&D to explore the potential of EVs in drug delivery and regenerative medicine.
• Partnerships: Collaborating with universities and biotech firms to enhance our understanding and application of EV technology.
• Commercialisation: Developing scalable solutions for the production and purification of EVs for therapeutic use.

Our state-of-the-art facilities are equipped with cutting-edge technology, enabling us to conduct high-quality research and produce reliable results. We are committed to maintaining the highest standards of quality and compliance in all our operations.

As we continue to grow, Extracellular remains focused on our goal of improving patient outcomes through innovative biotechnological solutions. Join us on our journey to transform healthcare and make a lasting impact on the lives of patients worldwide.